DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $215,123 | +3.4% | 867 | 0.0% | 0.07% | +6.1% |
Q2 2023 | $208,097 | -2.4% | 867 | +2.5% | 0.07% | -7.0% |
Q1 2023 | $213,241 | -5.0% | 846 | 0.0% | 0.07% | -12.3% |
Q4 2022 | $224,559 | +0.2% | 846 | -2.5% | 0.08% | -4.7% |
Q3 2022 | $224,000 | +1.8% | 868 | 0.0% | 0.08% | +7.6% |
Q2 2022 | $220,000 | -13.7% | 868 | 0.0% | 0.08% | -2.5% |
Q1 2022 | $255,000 | -12.1% | 868 | -1.6% | 0.08% | -11.0% |
Q4 2021 | $290,000 | +12.4% | 882 | +4.3% | 0.09% | +5.8% |
Q3 2021 | $258,000 | +13.7% | 846 | 0.0% | 0.09% | +17.8% |
Q2 2021 | $227,000 | +19.5% | 846 | 0.0% | 0.07% | +9.0% |
Q1 2021 | $190,000 | +2.2% | 846 | +1.2% | 0.07% | -5.6% |
Q4 2020 | $186,000 | +3.3% | 836 | 0.0% | 0.07% | -4.1% |
Q3 2020 | $180,000 | +40.6% | 836 | 0.0% | 0.07% | +34.5% |
Q4 2019 | $128,000 | +5.8% | 836 | 0.0% | 0.06% | -5.2% |
Q3 2019 | $121,000 | +1.7% | 836 | 0.0% | 0.06% | +1.8% |
Q2 2019 | $119,000 | +8.2% | 836 | 0.0% | 0.06% | +3.6% |
Q1 2019 | $110,000 | +685.7% | 836 | +514.7% | 0.06% | +587.5% |
Q4 2018 | $14,000 | – | 136 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |